| Name | Value |
|---|---|
| Revenues | 7,257.6K |
| Cost of Revenue | 4,962.2K |
| Gross Profit | 2,295.4K |
| Operating Expense | 2,595.4K |
| Operating I/L | -300.1K |
| Other Income/Expense | -136.5K |
| Interest Income | 9.5K |
| Pretax | -436.5K |
| Income Tax Expense | 1.3K |
| Net Income/Loss | -437.9K |
ImmuCell Corporation is an animal health company that develops, manufactures, and markets products to enhance the health and productivity of dairy and beef cattle. Its product line includes First Defense, a scours preventive product for newborn calves, Tri-Shield First Defense for the treatment of E. coli, coronavirus, and rotavirus, and the California Mastitis Test for detecting somatic cell counts in milk. The company also offers Dual-Force First Defense for the nutritional and feed supplement markets and is involved in developing Re-Tain, an intramammary treatment for subclinical mastitis in lactating dairy cows. ImmuCell sells its products through animal health distributors.